AgeX Therapeutics, Inc. (AGE)

Stock-Based Compensation

$3.13M

TTM · Period ending: · USD

AGE logo

AGE Stock-Based Compensation

Latest reported$3.13M
AGE Stock-Based Comp ($752.00K → $3.13M)
High-resolution chart · PNG

AGE stock-based compensation history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AgeX Therapeutics, Inc. Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
3,793,000
2,595,000
648,000
760,000
999,000
909,000
1,907,000
1,473,000
752,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.